Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IVF hartmann Holding AGXSWX:VBSN +1.92%74 FCF Margin % is 20.80% as of Dec. 2025, which is 100% above its 10-year median of 10.39. GuruFocus rates XSWX:VBSN with a GF Score™ of 74/100 and a GF Value™ of CHF143.27 (Fairly Valued). Among 816 Medical Devices & Instruments companies, IVF hartmann Holding AG ranks better than 75.61% on this metric.
The historical rank and industry rank for IVF hartmann Holding AG's FCF Margin % or its related term are showing as below:
XSWX:VBSN'
s FCF Margin % Range Over the Past 10 Years
Min: -6.22 Med: 10.39 Max: 21.23
Current: 10.81
During the past 13 years, the highest FCF Margin % of IVF hartmann Holding AG was 21.23%. The lowest was -6.22%. And the median was 10.39%.
XSWX:VBSN's FCF Margin % is ranked better than 75.61% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: -0.55
vs XSWX:VBSN: 10.81
IVF hartmann Holding AG FCF Margin % Related Terms
IVF hartmann Holding AG FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:VBSN vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, IVF hartmann Holding AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IVF hartmann Holding AG FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, IVF hartmann Holding AG's FCF Margin % distribution charts can be found below:
* The bar in red indicates where IVF hartmann Holding AG's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IVF hartmann Holding AG (XSWX:VBSN) has a FCF Margin % of 20.80% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on IVF hartmann Holding AG and its competitors. This is 100% above median its historical median of 10.39. According to the industry distribution chart, IVF hartmann Holding AG ranks #199 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 24.4%.
Is IVF hartmann Holding AG's FCF Margin % too high?
IVF hartmann Holding AG's current FCF Margin % of 20.80% is 100% above median its 10-year median of 10.39. Based on the distribution chart, IVF hartmann Holding AG ranks #199 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, IVF hartmann Holding AG has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IVF hartmann Holding AG's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, IVF hartmann Holding AG ranks #199 out of 816 companies for FCF Margin %. This places IVF hartmann Holding AG in the top 24% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on IVF hartmann Holding AG and its competitors. IVF hartmann Holding AG's current FCF Margin % is 20.80%, which is 100% above median its own 10-year median of 10.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IVF hartmann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, IVF hartmann Holding AG (XSWX:VBSN) is currently considered Fairly Valued. The stock's GF Value™ is CHF143.27, compared to a current price of CHF132.50 — trading 7.5% below its estimated fair value. The current FCF Margin % is 20.80%, which is 100% above median its 10-year median of 10.39. IVF hartmann Holding AG's overall GF Score™ is 74/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For IVF hartmann Holding AG (XSWX:VBSN), the current FCF Margin % is 20.80% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IVF hartmann Holding AG (XSWX:VBSN) Overvalued in 2026?
Based on GuruFocus' analysis, IVF hartmann Holding AG stock appears to be undervalued.
The current stock price of CHF132.50 is trading 7.5% below its estimated GF Value™ of CHF143.27.
GuruFocus considers IVF hartmann Holding AG to be Fairly Valued.
Key valuation signals for XSWX:VBSN:
FCF Margin %: 20.80% (100% above median its 10-year median of 10.39)
GF Value™: CHF143.27 vs. price of CHF132.50 (7.5% below fair value)
No single metric tells the full story. See the XSWX:VBSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IVF hartmann Holding AG engages in production and supply of medical, pharmaceutical and hygiene products in Switzerland, it offers products such as surgical disposable, disposable dental, first aid, therapeutic plaster, cotton wool, wound care among others. The company operates in four segment wound care, incontinence management, infection management and Other group activities.
74GF Score
Get the complete analysis for XSWX:VBSN
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:VBSN has been successfully added to your 
